AFL vs REPL · P/E 14, rev $18.93B vs $825.7M cap
Aflac Incorporated (AFL) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported AFL revenue for 2024-12-31 was $18.93B. Net income was $5.44B. Revenue was up 401.1% from 2023-12-31 to 2024-12-31. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
REPL does not have a complete income-statement cache yet.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. REPL currently screens at market cap $825.7M.
Not investment advice. Open the AFL and REPL stock pages for the full models.
Not investment advice.